Does Early PET/CT Assesment of Response to Chemotherapy Predicts Survival in Patients With Advanced Stage Non-Small-Cell Lung Cancer?

Ordu, Cetin; Selcuk, Nalan; Erdogan, Ezgi; Angin, Gulden; Gural, Zeynep; Memis, Hatice; Yencilek, Esin; Dalsuna, Sinem; Pilanci, Kezban

doi:10.1097/md.0000000000000299

Does Early PET/CT Assesment of Response to Chemotherapy Predicts Survival in Patients With Advanced Stage Non-Small-Cell Lung Cancer?

Atıf İçin Kopyala

Ordu C., Selcuk N. A., Erdogan E., Angin G., Gural Z., Memis H., ...Daha Fazla

MEDICINE, cilt.93, sa.28, 2014 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 93 Sayı: 28
Basım Tarihi: 2014
Doi Numarası: 10.1097/md.0000000000000299
Dergi Adı: MEDICINE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet

Özet

The aim of this study is to determine the prognostic role and the timing of metabolic response to chemotherapy, based on F-18-fluorodeoxyglucose positron emission tomography (F-18-FDG-PET), in patients with metastatic non-small-cell lung cancer (NSCLC).